Filing Details
- Accession Number:
- 0001127602-13-023273
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-23 15:34:01
- Reporting Period:
- 2013-07-19
- Filing Date:
- 2013-07-23
- Accepted Time:
- 2013-07-23 15:34:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 912183 | Cubist Pharmaceuticals Inc | CBST | Pharmaceutical Preparations (2834) | 223192085 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1456336 | Gregory Stea | 65 Hayden Avenue Lexington MA 02421 | Svp, Commercial Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-07-19 | 1,875 | $18.52 | 16,064 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-07-19 | 2,500 | $16.76 | 18,564 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-07-19 | 4,375 | $55.00 | 14,189 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2013-07-19 | 1,875 | $0.00 | 1,875 | $18.52 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2013-07-19 | 2,500 | $0.00 | 2,500 | $16.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-05-13 | 2019-02-13 | No | 4 | M | Direct |
| 0 | 2009-08-15 | 2019-05-15 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 317 | Indirect | 401(k) Plan |
Footnotes
- Sold pursuant to a Rule 10(b)5-1 Plan.
- Options vest 6.25% quarterly over a four-year period.
- Options vest 6.25% quarterly over a four-year period.
Billionaire Hedge Funds
